Review





Similar Products

93
MedChemExpress mouse primer sequences
Mouse Primer Sequences, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse primer sequences/product/MedChemExpress
Average 93 stars, based on 1 article reviews
mouse primer sequences - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

86
Sangon Biotech mouse fos qpcr primer pair
Mouse Fos Qpcr Primer Pair, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse fos qpcr primer pair/product/Sangon Biotech
Average 86 stars, based on 1 article reviews
mouse fos qpcr primer pair - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Sangon Biotech mouse klf6 qpcr primer pair
Mouse Klf6 Qpcr Primer Pair, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse klf6 qpcr primer pair/product/Sangon Biotech
Average 86 stars, based on 1 article reviews
mouse klf6 qpcr primer pair - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Sangon Biotech mouse actb qpcr primer pair
Mouse Actb Qpcr Primer Pair, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse actb qpcr primer pair/product/Sangon Biotech
Average 86 stars, based on 1 article reviews
mouse actb qpcr primer pair - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Sangon Biotech mouse jun qpcr primer pair
Mouse Jun Qpcr Primer Pair, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse jun qpcr primer pair/product/Sangon Biotech
Average 86 stars, based on 1 article reviews
mouse jun qpcr primer pair - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
10X Genomics xenium 5k mouse ptp priming oligos
Xenium 5k Mouse Ptp Priming Oligos, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xenium 5k mouse ptp priming oligos/product/10X Genomics
Average 86 stars, based on 1 article reviews
xenium 5k mouse ptp priming oligos - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Jackson Laboratory mtmg mouse strain genotyping primers
Related to . ( A ) Cdh5-tracking mouse lines. Tamoxifen switches on green fluorescence in cells that express the Cre-recombinase and their cell progeny. Confocal microscopy images of representative BM sections from Cdh5-Cre ERT2 (PAC)/ZsGreen ( B ) and Cdh5-Cre ERT2 (BAC)/ZsGreen ( C ) adult mice showing tamoxifen-induced ZsGreen fluorescence co-staining of most Endomucin + cells. Control BM sections from representative Cre + mouse treated with peanut oil (no tamoxifen) display occasional ZsGreen + Endomucin + cells but no tamoxifen-independent ZsGreen fluorescence is detected in representative Cre − mice. ( D ) Flow cytometry analysis of adult BM cells from Cdh5-Cre ERT2 (PAC)/ZsGreen ( n = 6–8) and Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 10) shows that ZsGreen fluorescence identifies most ECs 4 weeks after tamoxifen administration but also tracks a small proportion of EC expressing tamoxifen-independent fluorescence in Cre + but not Cre - mice. ( E ) Percent CD45 + ZsGreen + cells of viable BM cells from Cre − control ( n = 6), Cre + control (peanut oil treated, no tamoxifen; n = 8) and Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC) /ZsGreen ( n = 6) or Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 9). Mice were 8–12 weeks old at the time of tamoxifen administration. ( F ) Percent ZsGreen + cells of peripheral blood mononuclear cell (PBMC) from Cre − control, Cre + control (peanut oil treated), and Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC)/ZsGreen and Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 9/group). Mice were 8–12 weeks old at the time of tamoxifen administration. Representative flow cytometry gating of CD45 + EGFP + cells from BM and blood of <t>Cdh5-CreERT2/mTmG</t> mice ( G , relates to ), and CD45 + ZsGreen + cells from BM and blood of Cdh5-Cre ERT2 /ZsGreen mice ( H , relates to Figure S1E, F). ( I ) Representative confocal images showing a nucleated (DAPI + ) BM ZsGreen + CD45 + cell in the BM from a Cdh5-Cre ERT2 (PAC)/ZsGreen mouse treated with tamoxifen. ( J ) Percent ZsGreen + cells of PBMC in individual Cdh5-Cre ERT2 (BAC)/ZsGreen mice before or four weeks after tamoxifen administration. Each dot represents the results from 50 to 250 µl blood/mouse. The lines link results from individual mice ( n = 15, 8–12 weeks old). ( K ) Percent B and T-lymphocytes, granulocytes, and monocytes among EGFP + PBMC of Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC)/mTmG mice ( n = 15, 8–12 weeks old). ( L ) Percent EGFP + cells in peripheral blood cell populations of Cre + peanut oil-treated ( n = 9) and tamoxifen-treated ( n = 16) Cdh5-Cre ERT2 (PAC)/mTmG mice (8–12 weeks old). Dots represent individual mice. Data are shown as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t -test.
Mtmg Mouse Strain Genotyping Primers, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtmg mouse strain genotyping primers/product/Jackson Laboratory
Average 86 stars, based on 1 article reviews
mtmg mouse strain genotyping primers - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

94
OriGene mouse primer pairs
Related to . ( A ) Cdh5-tracking mouse lines. Tamoxifen switches on green fluorescence in cells that express the Cre-recombinase and their cell progeny. Confocal microscopy images of representative BM sections from Cdh5-Cre ERT2 (PAC)/ZsGreen ( B ) and Cdh5-Cre ERT2 (BAC)/ZsGreen ( C ) adult mice showing tamoxifen-induced ZsGreen fluorescence co-staining of most Endomucin + cells. Control BM sections from representative Cre + mouse treated with peanut oil (no tamoxifen) display occasional ZsGreen + Endomucin + cells but no tamoxifen-independent ZsGreen fluorescence is detected in representative Cre − mice. ( D ) Flow cytometry analysis of adult BM cells from Cdh5-Cre ERT2 (PAC)/ZsGreen ( n = 6–8) and Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 10) shows that ZsGreen fluorescence identifies most ECs 4 weeks after tamoxifen administration but also tracks a small proportion of EC expressing tamoxifen-independent fluorescence in Cre + but not Cre - mice. ( E ) Percent CD45 + ZsGreen + cells of viable BM cells from Cre − control ( n = 6), Cre + control (peanut oil treated, no tamoxifen; n = 8) and Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC) /ZsGreen ( n = 6) or Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 9). Mice were 8–12 weeks old at the time of tamoxifen administration. ( F ) Percent ZsGreen + cells of peripheral blood mononuclear cell (PBMC) from Cre − control, Cre + control (peanut oil treated), and Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC)/ZsGreen and Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 9/group). Mice were 8–12 weeks old at the time of tamoxifen administration. Representative flow cytometry gating of CD45 + EGFP + cells from BM and blood of <t>Cdh5-CreERT2/mTmG</t> mice ( G , relates to ), and CD45 + ZsGreen + cells from BM and blood of Cdh5-Cre ERT2 /ZsGreen mice ( H , relates to Figure S1E, F). ( I ) Representative confocal images showing a nucleated (DAPI + ) BM ZsGreen + CD45 + cell in the BM from a Cdh5-Cre ERT2 (PAC)/ZsGreen mouse treated with tamoxifen. ( J ) Percent ZsGreen + cells of PBMC in individual Cdh5-Cre ERT2 (BAC)/ZsGreen mice before or four weeks after tamoxifen administration. Each dot represents the results from 50 to 250 µl blood/mouse. The lines link results from individual mice ( n = 15, 8–12 weeks old). ( K ) Percent B and T-lymphocytes, granulocytes, and monocytes among EGFP + PBMC of Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC)/mTmG mice ( n = 15, 8–12 weeks old). ( L ) Percent EGFP + cells in peripheral blood cell populations of Cre + peanut oil-treated ( n = 9) and tamoxifen-treated ( n = 16) Cdh5-Cre ERT2 (PAC)/mTmG mice (8–12 weeks old). Dots represent individual mice. Data are shown as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t -test.
Mouse Primer Pairs, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse primer pairs/product/OriGene
Average 94 stars, based on 1 article reviews
mouse primer pairs - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

94
OriGene origene qstar
Related to . ( A ) Cdh5-tracking mouse lines. Tamoxifen switches on green fluorescence in cells that express the Cre-recombinase and their cell progeny. Confocal microscopy images of representative BM sections from Cdh5-Cre ERT2 (PAC)/ZsGreen ( B ) and Cdh5-Cre ERT2 (BAC)/ZsGreen ( C ) adult mice showing tamoxifen-induced ZsGreen fluorescence co-staining of most Endomucin + cells. Control BM sections from representative Cre + mouse treated with peanut oil (no tamoxifen) display occasional ZsGreen + Endomucin + cells but no tamoxifen-independent ZsGreen fluorescence is detected in representative Cre − mice. ( D ) Flow cytometry analysis of adult BM cells from Cdh5-Cre ERT2 (PAC)/ZsGreen ( n = 6–8) and Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 10) shows that ZsGreen fluorescence identifies most ECs 4 weeks after tamoxifen administration but also tracks a small proportion of EC expressing tamoxifen-independent fluorescence in Cre + but not Cre - mice. ( E ) Percent CD45 + ZsGreen + cells of viable BM cells from Cre − control ( n = 6), Cre + control (peanut oil treated, no tamoxifen; n = 8) and Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC) /ZsGreen ( n = 6) or Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 9). Mice were 8–12 weeks old at the time of tamoxifen administration. ( F ) Percent ZsGreen + cells of peripheral blood mononuclear cell (PBMC) from Cre − control, Cre + control (peanut oil treated), and Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC)/ZsGreen and Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 9/group). Mice were 8–12 weeks old at the time of tamoxifen administration. Representative flow cytometry gating of CD45 + EGFP + cells from BM and blood of <t>Cdh5-CreERT2/mTmG</t> mice ( G , relates to ), and CD45 + ZsGreen + cells from BM and blood of Cdh5-Cre ERT2 /ZsGreen mice ( H , relates to Figure S1E, F). ( I ) Representative confocal images showing a nucleated (DAPI + ) BM ZsGreen + CD45 + cell in the BM from a Cdh5-Cre ERT2 (PAC)/ZsGreen mouse treated with tamoxifen. ( J ) Percent ZsGreen + cells of PBMC in individual Cdh5-Cre ERT2 (BAC)/ZsGreen mice before or four weeks after tamoxifen administration. Each dot represents the results from 50 to 250 µl blood/mouse. The lines link results from individual mice ( n = 15, 8–12 weeks old). ( K ) Percent B and T-lymphocytes, granulocytes, and monocytes among EGFP + PBMC of Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC)/mTmG mice ( n = 15, 8–12 weeks old). ( L ) Percent EGFP + cells in peripheral blood cell populations of Cre + peanut oil-treated ( n = 9) and tamoxifen-treated ( n = 16) Cdh5-Cre ERT2 (PAC)/mTmG mice (8–12 weeks old). Dots represent individual mice. Data are shown as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t -test.
Origene Qstar, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/origene qstar/product/OriGene
Average 94 stars, based on 1 article reviews
origene qstar - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

94
Cyagen Biosciences n a otof q 939x q939x mice cyagen n a c57bl 6j mice cyagen n a oligonucleotides primers
Related to . ( A ) Cdh5-tracking mouse lines. Tamoxifen switches on green fluorescence in cells that express the Cre-recombinase and their cell progeny. Confocal microscopy images of representative BM sections from Cdh5-Cre ERT2 (PAC)/ZsGreen ( B ) and Cdh5-Cre ERT2 (BAC)/ZsGreen ( C ) adult mice showing tamoxifen-induced ZsGreen fluorescence co-staining of most Endomucin + cells. Control BM sections from representative Cre + mouse treated with peanut oil (no tamoxifen) display occasional ZsGreen + Endomucin + cells but no tamoxifen-independent ZsGreen fluorescence is detected in representative Cre − mice. ( D ) Flow cytometry analysis of adult BM cells from Cdh5-Cre ERT2 (PAC)/ZsGreen ( n = 6–8) and Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 10) shows that ZsGreen fluorescence identifies most ECs 4 weeks after tamoxifen administration but also tracks a small proportion of EC expressing tamoxifen-independent fluorescence in Cre + but not Cre - mice. ( E ) Percent CD45 + ZsGreen + cells of viable BM cells from Cre − control ( n = 6), Cre + control (peanut oil treated, no tamoxifen; n = 8) and Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC) /ZsGreen ( n = 6) or Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 9). Mice were 8–12 weeks old at the time of tamoxifen administration. ( F ) Percent ZsGreen + cells of peripheral blood mononuclear cell (PBMC) from Cre − control, Cre + control (peanut oil treated), and Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC)/ZsGreen and Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 9/group). Mice were 8–12 weeks old at the time of tamoxifen administration. Representative flow cytometry gating of CD45 + EGFP + cells from BM and blood of <t>Cdh5-CreERT2/mTmG</t> mice ( G , relates to ), and CD45 + ZsGreen + cells from BM and blood of Cdh5-Cre ERT2 /ZsGreen mice ( H , relates to Figure S1E, F). ( I ) Representative confocal images showing a nucleated (DAPI + ) BM ZsGreen + CD45 + cell in the BM from a Cdh5-Cre ERT2 (PAC)/ZsGreen mouse treated with tamoxifen. ( J ) Percent ZsGreen + cells of PBMC in individual Cdh5-Cre ERT2 (BAC)/ZsGreen mice before or four weeks after tamoxifen administration. Each dot represents the results from 50 to 250 µl blood/mouse. The lines link results from individual mice ( n = 15, 8–12 weeks old). ( K ) Percent B and T-lymphocytes, granulocytes, and monocytes among EGFP + PBMC of Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC)/mTmG mice ( n = 15, 8–12 weeks old). ( L ) Percent EGFP + cells in peripheral blood cell populations of Cre + peanut oil-treated ( n = 9) and tamoxifen-treated ( n = 16) Cdh5-Cre ERT2 (PAC)/mTmG mice (8–12 weeks old). Dots represent individual mice. Data are shown as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t -test.
N A Otof Q 939x Q939x Mice Cyagen N A C57bl 6j Mice Cyagen N A Oligonucleotides Primers, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/n a otof q 939x q939x mice cyagen n a c57bl 6j mice cyagen n a oligonucleotides primers/product/Cyagen Biosciences
Average 94 stars, based on 1 article reviews
n a otof q 939x q939x mice cyagen n a c57bl 6j mice cyagen n a oligonucleotides primers - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

Image Search Results


Related to . ( A ) Cdh5-tracking mouse lines. Tamoxifen switches on green fluorescence in cells that express the Cre-recombinase and their cell progeny. Confocal microscopy images of representative BM sections from Cdh5-Cre ERT2 (PAC)/ZsGreen ( B ) and Cdh5-Cre ERT2 (BAC)/ZsGreen ( C ) adult mice showing tamoxifen-induced ZsGreen fluorescence co-staining of most Endomucin + cells. Control BM sections from representative Cre + mouse treated with peanut oil (no tamoxifen) display occasional ZsGreen + Endomucin + cells but no tamoxifen-independent ZsGreen fluorescence is detected in representative Cre − mice. ( D ) Flow cytometry analysis of adult BM cells from Cdh5-Cre ERT2 (PAC)/ZsGreen ( n = 6–8) and Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 10) shows that ZsGreen fluorescence identifies most ECs 4 weeks after tamoxifen administration but also tracks a small proportion of EC expressing tamoxifen-independent fluorescence in Cre + but not Cre - mice. ( E ) Percent CD45 + ZsGreen + cells of viable BM cells from Cre − control ( n = 6), Cre + control (peanut oil treated, no tamoxifen; n = 8) and Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC) /ZsGreen ( n = 6) or Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 9). Mice were 8–12 weeks old at the time of tamoxifen administration. ( F ) Percent ZsGreen + cells of peripheral blood mononuclear cell (PBMC) from Cre − control, Cre + control (peanut oil treated), and Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC)/ZsGreen and Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 9/group). Mice were 8–12 weeks old at the time of tamoxifen administration. Representative flow cytometry gating of CD45 + EGFP + cells from BM and blood of Cdh5-CreERT2/mTmG mice ( G , relates to ), and CD45 + ZsGreen + cells from BM and blood of Cdh5-Cre ERT2 /ZsGreen mice ( H , relates to Figure S1E, F). ( I ) Representative confocal images showing a nucleated (DAPI + ) BM ZsGreen + CD45 + cell in the BM from a Cdh5-Cre ERT2 (PAC)/ZsGreen mouse treated with tamoxifen. ( J ) Percent ZsGreen + cells of PBMC in individual Cdh5-Cre ERT2 (BAC)/ZsGreen mice before or four weeks after tamoxifen administration. Each dot represents the results from 50 to 250 µl blood/mouse. The lines link results from individual mice ( n = 15, 8–12 weeks old). ( K ) Percent B and T-lymphocytes, granulocytes, and monocytes among EGFP + PBMC of Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC)/mTmG mice ( n = 15, 8–12 weeks old). ( L ) Percent EGFP + cells in peripheral blood cell populations of Cre + peanut oil-treated ( n = 9) and tamoxifen-treated ( n = 16) Cdh5-Cre ERT2 (PAC)/mTmG mice (8–12 weeks old). Dots represent individual mice. Data are shown as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t -test.

Journal: eLife

Article Title: Single-cell lineage tracing identifies hemogenic endothelial cells in the adult mouse bone marrow

doi: 10.7554/eLife.109553

Figure Lengend Snippet: Related to . ( A ) Cdh5-tracking mouse lines. Tamoxifen switches on green fluorescence in cells that express the Cre-recombinase and their cell progeny. Confocal microscopy images of representative BM sections from Cdh5-Cre ERT2 (PAC)/ZsGreen ( B ) and Cdh5-Cre ERT2 (BAC)/ZsGreen ( C ) adult mice showing tamoxifen-induced ZsGreen fluorescence co-staining of most Endomucin + cells. Control BM sections from representative Cre + mouse treated with peanut oil (no tamoxifen) display occasional ZsGreen + Endomucin + cells but no tamoxifen-independent ZsGreen fluorescence is detected in representative Cre − mice. ( D ) Flow cytometry analysis of adult BM cells from Cdh5-Cre ERT2 (PAC)/ZsGreen ( n = 6–8) and Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 10) shows that ZsGreen fluorescence identifies most ECs 4 weeks after tamoxifen administration but also tracks a small proportion of EC expressing tamoxifen-independent fluorescence in Cre + but not Cre - mice. ( E ) Percent CD45 + ZsGreen + cells of viable BM cells from Cre − control ( n = 6), Cre + control (peanut oil treated, no tamoxifen; n = 8) and Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC) /ZsGreen ( n = 6) or Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 9). Mice were 8–12 weeks old at the time of tamoxifen administration. ( F ) Percent ZsGreen + cells of peripheral blood mononuclear cell (PBMC) from Cre − control, Cre + control (peanut oil treated), and Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC)/ZsGreen and Cdh5-Cre ERT2 (BAC)/ZsGreen mice ( n = 9/group). Mice were 8–12 weeks old at the time of tamoxifen administration. Representative flow cytometry gating of CD45 + EGFP + cells from BM and blood of Cdh5-CreERT2/mTmG mice ( G , relates to ), and CD45 + ZsGreen + cells from BM and blood of Cdh5-Cre ERT2 /ZsGreen mice ( H , relates to Figure S1E, F). ( I ) Representative confocal images showing a nucleated (DAPI + ) BM ZsGreen + CD45 + cell in the BM from a Cdh5-Cre ERT2 (PAC)/ZsGreen mouse treated with tamoxifen. ( J ) Percent ZsGreen + cells of PBMC in individual Cdh5-Cre ERT2 (BAC)/ZsGreen mice before or four weeks after tamoxifen administration. Each dot represents the results from 50 to 250 µl blood/mouse. The lines link results from individual mice ( n = 15, 8–12 weeks old). ( K ) Percent B and T-lymphocytes, granulocytes, and monocytes among EGFP + PBMC of Cre + tamoxifen-treated Cdh5-Cre ERT2 (PAC)/mTmG mice ( n = 15, 8–12 weeks old). ( L ) Percent EGFP + cells in peripheral blood cell populations of Cre + peanut oil-treated ( n = 9) and tamoxifen-treated ( n = 16) Cdh5-Cre ERT2 (PAC)/mTmG mice (8–12 weeks old). Dots represent individual mice. Data are shown as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t -test.

Article Snippet: Sequence-based reagent , mTmG mouse strain genotyping primers (5′–3′) , CTT TAA GCC TGC CCA GAA GA TAG AGC TTG CGG AAC CCT TC AGG GAG CTG CAG TGG AGT AG , JAX: 007676 , .

Techniques: Fluorescence, Confocal Microscopy, Staining, Control, Flow Cytometry, Expressing

( A ) Experimental design: tamoxifen was administered to 8- to 12-week-old Cdh5-Cre mice to induce fluorescent labeling of VE-Cadherin + cells and their cell progeny. Four weeks later, BM and blood were analyzed. ( B ) CD31 + EGFP + BM ECs in Cre − mice ( n = 10) and Cre + mice treated with oil ( n = 13) or tamoxifen ( n = 10); flow cytometry results. ( C, D ) CD45 + EGFP + cells in BM and blood from Cre − mice ( n = 8) and Cre + mice treated with oil ( n = 6–10) or tamoxifen ( n = 15–18). Representative flow cytometry gating in . ( E ) Representative blood smear from a tamoxifen-treated Cdh5-Cre ERT2 (PAC)/ZsGreen mouse showing ZsGreen + CD45 + DAPI + cells (arrows). ( F ) Kinetics of ZsGreen + cell detection in BM ECs (CD45⁻VE-Cadherin + ) and blood white blood cells (WBCs) post-tamoxifen; mouse n = 8–10/group. ( G ) EGFP + B and T-lymphocytes, granulocytes, and monocytes in BM of tamoxifen-treated mice ( n = 14) as percent of total EGFP + cells; three experiments. ( H ) EGFP + BM LSK, lymphocytes, granulocytes, and monocytes as percent of total EGFP +/− cell type; Cdh5-Cre ERT2 (PAC)/mTmG mice (oil n = 10; tamoxifen n = 15), three experiments. ( I ) Uniform Manifold Approximation and Projection (UMAP) plots of Lin − BM hematopoietic stem and progenitor cell (HSPC) from tamoxifen-treated Cdh5-Cre ERT2 (PAC)/ZsGreen mice ( n = 26; 1 femur/mouse) showing FlowSOM clustering of all (ZsGreen +/− ) and ZsGreen + populations. ( J ) Violin plots showing ZsGreen + cell distribution across HSPC subsets from ( I ). Dots represent individual mice; data shown as mean ± SD except shown as median in ( G ). *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t -test.

Journal: eLife

Article Title: Single-cell lineage tracing identifies hemogenic endothelial cells in the adult mouse bone marrow

doi: 10.7554/eLife.109553

Figure Lengend Snippet: ( A ) Experimental design: tamoxifen was administered to 8- to 12-week-old Cdh5-Cre mice to induce fluorescent labeling of VE-Cadherin + cells and their cell progeny. Four weeks later, BM and blood were analyzed. ( B ) CD31 + EGFP + BM ECs in Cre − mice ( n = 10) and Cre + mice treated with oil ( n = 13) or tamoxifen ( n = 10); flow cytometry results. ( C, D ) CD45 + EGFP + cells in BM and blood from Cre − mice ( n = 8) and Cre + mice treated with oil ( n = 6–10) or tamoxifen ( n = 15–18). Representative flow cytometry gating in . ( E ) Representative blood smear from a tamoxifen-treated Cdh5-Cre ERT2 (PAC)/ZsGreen mouse showing ZsGreen + CD45 + DAPI + cells (arrows). ( F ) Kinetics of ZsGreen + cell detection in BM ECs (CD45⁻VE-Cadherin + ) and blood white blood cells (WBCs) post-tamoxifen; mouse n = 8–10/group. ( G ) EGFP + B and T-lymphocytes, granulocytes, and monocytes in BM of tamoxifen-treated mice ( n = 14) as percent of total EGFP + cells; three experiments. ( H ) EGFP + BM LSK, lymphocytes, granulocytes, and monocytes as percent of total EGFP +/− cell type; Cdh5-Cre ERT2 (PAC)/mTmG mice (oil n = 10; tamoxifen n = 15), three experiments. ( I ) Uniform Manifold Approximation and Projection (UMAP) plots of Lin − BM hematopoietic stem and progenitor cell (HSPC) from tamoxifen-treated Cdh5-Cre ERT2 (PAC)/ZsGreen mice ( n = 26; 1 femur/mouse) showing FlowSOM clustering of all (ZsGreen +/− ) and ZsGreen + populations. ( J ) Violin plots showing ZsGreen + cell distribution across HSPC subsets from ( I ). Dots represent individual mice; data shown as mean ± SD except shown as median in ( G ). *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t -test.

Article Snippet: Sequence-based reagent , mTmG mouse strain genotyping primers (5′–3′) , CTT TAA GCC TGC CCA GAA GA TAG AGC TTG CGG AAC CCT TC AGG GAG CTG CAG TGG AGT AG , JAX: 007676 , .

Techniques: Labeling, Flow Cytometry

( A ) Transplantation experiment: donor LSK sorting, recipient irradiation, transplantation, tamoxifen treatment, and analysis (top). Tabular representation of possible outcomes of the experiment designed to address the question ‘Do HSPCs/other hematopoietic cells in Cdh5Cre ERT2 /ZsGreen mice express Cdh5-Cre ERT2 ?’ (bottom). Blood WBC counts ( B ), percent ZsGreen + peripheral blood mononuclear cell (PBMC) ( C ), and time course of ZsGreen + PBMC detection ( D ) in transplant recipients of ZsGreen − LSK (5 × 10 4 or 2.5 × 10 4 cells/mouse; n = 3/group) and ZsGreen-enriched LSKs (2.8 × 10 3 cells/mouse; n = 2). Results in B and C are from week 24 post-tamoxifen. ( E ) Experiment: WT BM transplantation (BMTP) into lethally irradiated Cdh5-Cre/mTmG mice ( n = 9). Four weeks later, tamoxifen was administered; blood was monitored for 16 weeks. EGFP + PBMC detection before and after tamoxifen or peanut oil administration ( F ) and cell type distribution of EGFP + and EGFP − PBMCs at week 12 post-tamoxifen or peanut oil ( G ) in Cdh5-Cre/mTmG recipients ( n = 9) of WT BM (5 × 10 6 cells). Statistical significance reflects comparisons between EGFP + and EGFP − cells in the tamoxifen versus peanut oil groups. Dots represent individual mice. Data are shown as mean ± SD. ***p < 0.001, ns, not significant by Student’s t -test.

Journal: eLife

Article Title: Single-cell lineage tracing identifies hemogenic endothelial cells in the adult mouse bone marrow

doi: 10.7554/eLife.109553

Figure Lengend Snippet: ( A ) Transplantation experiment: donor LSK sorting, recipient irradiation, transplantation, tamoxifen treatment, and analysis (top). Tabular representation of possible outcomes of the experiment designed to address the question ‘Do HSPCs/other hematopoietic cells in Cdh5Cre ERT2 /ZsGreen mice express Cdh5-Cre ERT2 ?’ (bottom). Blood WBC counts ( B ), percent ZsGreen + peripheral blood mononuclear cell (PBMC) ( C ), and time course of ZsGreen + PBMC detection ( D ) in transplant recipients of ZsGreen − LSK (5 × 10 4 or 2.5 × 10 4 cells/mouse; n = 3/group) and ZsGreen-enriched LSKs (2.8 × 10 3 cells/mouse; n = 2). Results in B and C are from week 24 post-tamoxifen. ( E ) Experiment: WT BM transplantation (BMTP) into lethally irradiated Cdh5-Cre/mTmG mice ( n = 9). Four weeks later, tamoxifen was administered; blood was monitored for 16 weeks. EGFP + PBMC detection before and after tamoxifen or peanut oil administration ( F ) and cell type distribution of EGFP + and EGFP − PBMCs at week 12 post-tamoxifen or peanut oil ( G ) in Cdh5-Cre/mTmG recipients ( n = 9) of WT BM (5 × 10 6 cells). Statistical significance reflects comparisons between EGFP + and EGFP − cells in the tamoxifen versus peanut oil groups. Dots represent individual mice. Data are shown as mean ± SD. ***p < 0.001, ns, not significant by Student’s t -test.

Article Snippet: Sequence-based reagent , mTmG mouse strain genotyping primers (5′–3′) , CTT TAA GCC TGC CCA GAA GA TAG AGC TTG CGG AAC CCT TC AGG GAG CTG CAG TGG AGT AG , JAX: 007676 , .

Techniques: Transplantation Assay, Irradiation

Related to . ( A ) Schematic representation of the Col1a2 tracking lines. ( B ) Representative confocal image of a BM section from a tamoxifen-treated Col1a2-Cre ERT2 /ZsGreen mouse, showing widespread distribution of ZsGreen + cells. Flow cytometric identification of RUNX1 + VE-Cadherin + CD45 − endothelial cells (ECs) in the BM of peanut oil-treated ( n = 6) and tamoxifen-treated ( n = 6) Col1a2-Cre ERT2 /ZsGreen adult mice; Cre − mice ( n = 5) ( C ); WT C57Bl/6 mice ( n = 6) and Fluorescence Minus One (FMO) control ( n = 5) ( D ); and Cdh5-Cre ERT2 (PAC)/ZsGreen mice treated with peanut oil ( n = 6) or tamoxifen ( n = 6); Cre − mice ( n = 5) ( E ). Left panels: quantification of cells identified by the indicated gates as a percentage of total BM ECs; each dot represents one mouse (1 femur + 1 tibia). Middle and right panels: representative gating strategies. ( F ) Representative confocal microscopy image of a BM section from a tamoxifen-treated Col1a2-Cre ERT2 /ZsGreen adult mouse showing a ZsGreen + Endomucin + cell lining a vascular structure (white arrows). ( G ) Representative confocal image of a blood smear from a Col1a2-Cre ERT2 /ZsGreen mouse treated with tamoxifen showing the presence of a nucleate CD45 + cell tracked by ZsGreen/Col1a2 fluorescence (pointed by the arrow). ( H ) Representative confocal image of a blood smear from a Col1a2-Cre ERT2 /mTmG mouse treated with tamoxifen showing the presence of a nucleated CD45 + cell tracked by EGFP/Col1a2 fluorescence (pointed by the arrow). Dots represent individual mice. Data are shown as mean ± SD. ***p < 0.001 by Student’s t -test.

Journal: eLife

Article Title: Single-cell lineage tracing identifies hemogenic endothelial cells in the adult mouse bone marrow

doi: 10.7554/eLife.109553

Figure Lengend Snippet: Related to . ( A ) Schematic representation of the Col1a2 tracking lines. ( B ) Representative confocal image of a BM section from a tamoxifen-treated Col1a2-Cre ERT2 /ZsGreen mouse, showing widespread distribution of ZsGreen + cells. Flow cytometric identification of RUNX1 + VE-Cadherin + CD45 − endothelial cells (ECs) in the BM of peanut oil-treated ( n = 6) and tamoxifen-treated ( n = 6) Col1a2-Cre ERT2 /ZsGreen adult mice; Cre − mice ( n = 5) ( C ); WT C57Bl/6 mice ( n = 6) and Fluorescence Minus One (FMO) control ( n = 5) ( D ); and Cdh5-Cre ERT2 (PAC)/ZsGreen mice treated with peanut oil ( n = 6) or tamoxifen ( n = 6); Cre − mice ( n = 5) ( E ). Left panels: quantification of cells identified by the indicated gates as a percentage of total BM ECs; each dot represents one mouse (1 femur + 1 tibia). Middle and right panels: representative gating strategies. ( F ) Representative confocal microscopy image of a BM section from a tamoxifen-treated Col1a2-Cre ERT2 /ZsGreen adult mouse showing a ZsGreen + Endomucin + cell lining a vascular structure (white arrows). ( G ) Representative confocal image of a blood smear from a Col1a2-Cre ERT2 /ZsGreen mouse treated with tamoxifen showing the presence of a nucleate CD45 + cell tracked by ZsGreen/Col1a2 fluorescence (pointed by the arrow). ( H ) Representative confocal image of a blood smear from a Col1a2-Cre ERT2 /mTmG mouse treated with tamoxifen showing the presence of a nucleated CD45 + cell tracked by EGFP/Col1a2 fluorescence (pointed by the arrow). Dots represent individual mice. Data are shown as mean ± SD. ***p < 0.001 by Student’s t -test.

Article Snippet: Sequence-based reagent , mTmG mouse strain genotyping primers (5′–3′) , CTT TAA GCC TGC CCA GAA GA TAG AGC TTG CGG AAC CCT TC AGG GAG CTG CAG TGG AGT AG , JAX: 007676 , .

Techniques: Fluorescence, Control, Confocal Microscopy

Percent EGFP + CD45 + cells in bone marrow (BM) and blood of tamoxifen-treated ( n = 6) or oil-treated ( n = 5) Col1a2-Cre ERT2 /mTmG mice ( A ) and tamoxifen-treated ( n = 4) or oil-treated ( n = 3) Col1a2-Cre ERT2 /ZsGreen mice ( B ). Cre-control mice ( n = 5 in A, and n = 2 in B). ( C ) Transplant experiment: sorted VE-Cadherin + CD45 − ZsGreen + /Col1a2 + cells from tamoxifen-treated Col1a2-Cre ERT2 /ZsGreen mice are transplanted into 5-FU-conditioned WT recipients. Detection ( D ) and characterization ( E ) of ZsGreen + CD45 + cells in BM and blood of WT 5-FU-conditioned mice ( n = 5), 4 weeks post-transplant of VE-Cadherin + CD45⁻ZsGreen + /Col1a2 + cells. Control FU-conditioned WT mice ( n = 4) received no cell transplant ( D ). ( F ) Time course of ZsGreen + peripheral blood mononuclear cell (PBMC) detection in control (Cdh5-Cre + /ZsGreen + ) and Runx1 EC-KI (Cdh5-Cre + /ZsGreen + /Runx1-KI) mice ( n = 10 per group). Representative images ( G ) and quantification ( H ) of ZsGreen + cells from OP9 cell-supported cultures of BM cells from tamoxifen-treated Cdh5-Cre + /ZsGreen + ( n = 11) and Runx1 EC-KI mice ( n = 5). Representative flow cytometry plots ( I ) and quantification ( J ) of CD45 + ZsGreen + cells from OP9 cell-supported BM cell cultures ( n = 5/group). Dots represent individual mice. Data are shown as mean ± SD. **p < 0.01, ***p < 0.001 by Student’s t -test.

Journal: eLife

Article Title: Single-cell lineage tracing identifies hemogenic endothelial cells in the adult mouse bone marrow

doi: 10.7554/eLife.109553

Figure Lengend Snippet: Percent EGFP + CD45 + cells in bone marrow (BM) and blood of tamoxifen-treated ( n = 6) or oil-treated ( n = 5) Col1a2-Cre ERT2 /mTmG mice ( A ) and tamoxifen-treated ( n = 4) or oil-treated ( n = 3) Col1a2-Cre ERT2 /ZsGreen mice ( B ). Cre-control mice ( n = 5 in A, and n = 2 in B). ( C ) Transplant experiment: sorted VE-Cadherin + CD45 − ZsGreen + /Col1a2 + cells from tamoxifen-treated Col1a2-Cre ERT2 /ZsGreen mice are transplanted into 5-FU-conditioned WT recipients. Detection ( D ) and characterization ( E ) of ZsGreen + CD45 + cells in BM and blood of WT 5-FU-conditioned mice ( n = 5), 4 weeks post-transplant of VE-Cadherin + CD45⁻ZsGreen + /Col1a2 + cells. Control FU-conditioned WT mice ( n = 4) received no cell transplant ( D ). ( F ) Time course of ZsGreen + peripheral blood mononuclear cell (PBMC) detection in control (Cdh5-Cre + /ZsGreen + ) and Runx1 EC-KI (Cdh5-Cre + /ZsGreen + /Runx1-KI) mice ( n = 10 per group). Representative images ( G ) and quantification ( H ) of ZsGreen + cells from OP9 cell-supported cultures of BM cells from tamoxifen-treated Cdh5-Cre + /ZsGreen + ( n = 11) and Runx1 EC-KI mice ( n = 5). Representative flow cytometry plots ( I ) and quantification ( J ) of CD45 + ZsGreen + cells from OP9 cell-supported BM cell cultures ( n = 5/group). Dots represent individual mice. Data are shown as mean ± SD. **p < 0.01, ***p < 0.001 by Student’s t -test.

Article Snippet: Sequence-based reagent , mTmG mouse strain genotyping primers (5′–3′) , CTT TAA GCC TGC CCA GAA GA TAG AGC TTG CGG AAC CCT TC AGG GAG CTG CAG TGG AGT AG , JAX: 007676 , .

Techniques: Control, Flow Cytometry